NASDAQ: RDHL - RedHill Biopharma Ltd.

Доходность за полгода: -24.35%
Сектор: Healthcare

График акции RedHill Biopharma Ltd.


О компании

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults.

Подробнее
Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

Основные параметры

ISIN US7574681034
Цена ао 0.4797
Выручка 0.0063
EBITDA -0.0407
P/S 28.04
P/BV 2.94
EV/EBITDA -3.72
Число акций ао 0.00648 млрд
Сайт https://www.redhillbio.com
P/E 0.3992
Изменение цены за день: +2.61% (0.4254)
Изменение цены за неделю: -16.7% (0.524)
Изменение цены за месяц: -17.49% (0.529)
Изменение цены за 3 месяца: -58.82% (1.06)
Изменение цены за полгода: -24.35% (0.577)
Изменение цены за год: -86.4% (3.21)
Изменение цены с начала года: -61.71% (1.14)


Все параметры ⇨

Оценка

Недооценка

Название Значение Оценка
P/S 28.04 9
P/BV 2.94 3
P/E 0.3992 10
EV/EBITDA -3.72 0
Итого:

Эффективность

Название Значение Оценка
ROA, % 26.23 8
ROE, % -102.97 0
Итого:

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого:

Долг

Название Значение Оценка
Debt/EBITDA -0.0408 10
Итого:

Импульс роста

Название Значение Оценка
Рост прибыли, % -12.02 0
Рост цены акции, % 0 0
Рост дивидендов, % 0 0
Итого:

Основные владельцы

Институционалы Объем Доля, %
Gagnon Securities, LLC 89589 10.16
JANE STREET GROUP, LLC 86812 9.85
Rhumbline Advisers 34847 3.95
We Are One Seven, LLC 15750 1.79
Squarepoint Ops LLC 10947 1.24
Group One Trading, L.P. 615 0.07
Morgan Stanley 576 0.07
Aspire Private Capital, LLC 405 0.05
Royal Bank of Canada 142 0.02
Steward Partners Investment Advisory, LLC 125 0.01

Похожие компании



Руководство компании

Руководитель Должность Оплата Год рождения
Mr. Dror Ben-Asher Co-Founder, Chairman & CEO 594.61k 1966 (58 лет)
Mr. Gilead Raday MPhil, MSc Chief Operating Officer 365.56k 1975 (49 лет)
Mr. Adi Frish Chief Corporate & Business Development Officer 339.3k 1970 (54 года)
Mr. Rick D. Scruggs Chief Commercial Officer, President of RedHill Biopharma Inc. & Director 469.8k 1960 (64 года)
Mr. Razi Ingber Chief Financial Officer 339.82k 1984 (40 лет)
Ms. Alexandra Okmian Senior Business Development & Investor Relations Manager N/A
Dr. Reza Fathi Ph.D. Senior Vice President of Research & Development 299.29k 1955 (69 лет)
Dr. June S. Almenoff FACP, M.D., Ph.D. Chief Medical Officer N/A 1957 (67 лет)
Ms. Patricia Anderson B.Sc. RAC Senior Vice President of Regulatory Affairs N/A
Mr. Guy Goldberg J.D. Chief Business Officer 338.13k 1976 (48 лет)

Информация о компании

Адрес: Israel, Tel Aviv, 21 Ha’arba’a Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.redhillbio.com
Телефон: +tel:97235413131